Abstract:figure legend Human intestinal organoids were genetically modified to express a fluorescent protein in enteroendocrine cells (EECs), which were then separated by flow cytometry and analysed by single‐cell RNA sequencing. High numbers of human EECs were thereby available for cluster analysis and differential gene expression, revealing transcriptomic differences between EEC populations. Gut hormones control intestinal function, metabolism and appetite, and have been harnessed therapeutically to treat type 2 diabetes and obesity. Our understanding of the enteroendocrine axis arises largely from animal studies, but intestinal organoid models make it possible to identify, genetically modify and purify human enteroendocrine cells (EECs). This study aimed to map human EECs using single‐cell RNA sequencing. Organoids derived from human duodenum and ileum were genetically modified using CRISPR‐Cas9 to express the fluorescent protein Venus driven by the chromogranin‐A promoter. Fluorescent cells from CHGA‐Venus organoids were purified by flow cytometry and analysed by 10X single‐cell RNA sequencing. Cluster analysis separated EEC populations, allowing an examination of differentially expressed hormones, nutrient‐sensing machinery, transcription factors and exocytotic machinery. Bile acid receptor GPBAR1 was most highly expressed in L‐cells (producing glucagon‐like peptide 1 and peptide YY), long‐chain fatty acid receptor FFAR1 was highest in I‐cells (cholecystokinin), K‐cells (glucose‐dependent insulinotropic polypeptide) and L‐cells, short‐chain fatty acid receptor FFAR2 was highest in ileal L‐cells and enterochromaffin cells, olfactory receptor OR51E1 was notably expressed in ileal enterochromaffin cells, and the glucose‐sensing sodium glucose cotransporter SLC5A1 was highly and differentially expressed in K‐ and L‐cells, reflecting their known responsiveness to ingested glucose. The organoid EEC atlas was merged with published data from human intestine and organoids, with good overlap between enteroendocrine datasets. Understanding the similarities and differences between human EEC types will facilitate the development of drugs targeting the enteroendocrine axis for the treatment of conditions such as diabetes, obesity and intestinal disorders. Key points Gut hormones regulate intestinal function, nutrient homeostasis and metabolism and form the basis of the new classes of drugs for obesity and diabetes. As enteroendocrine cells (EECs) comprise only ∼1% of the intestinal epithelium, they are under‐represented in current single‐cell atlases. To identify, compare and characterise human EECs we generated chromogranin‐A labelled organoids from duodenal and ileal biopsies by CRISPR‐Cas9. Fluorescent chromogranin‐A positive EECs were purified and analysed by single‐cell RNA sequencing, revealing predominant cell clusters producing different gut hormones. Cell clusters exhibited differential expression of nutrient‐sensing machinery including bile acid receptors, long‐ and short‐chain fatty acid receptors and glucose transporters. Organoid‐derived EECs mapped well onto data from native intestinal cell populations, extending coverage of EECs.

Molecular mechanisms underlying glucose-dependent insulinotropic polypeptide secretion in human duodenal organoids

K-cells and glucose-dependent insulinotropic polypeptide in health and disease

Carbohydrate‐induced secretion of glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1

Altered desensitization and internalization patterns of rodent versus human glucose-dependent insulinotropic polypeptide (GIP) receptors. An important drug discovery challenge

Glucose-Dependent Insulinotropic Polypeptide Receptor-Expressing Cells in the Hypothalamus Regulate Food Intake

Activation of Gs signaling in mouse enteroendocrine K-cells greatly improves obesity- and diabetes-related metabolic deficits

Stimulating intestinal GIP release reduces food intake and body weight in mice

Exploring the functional, protective, and transcriptomic effects of GIP on cytokine-exposed human pancreatic islets and EndoC-βH5 cells

Differential processing of pro-glucose-dependent insulinotropic polypeptide in gut

Mechanistic insights into the detection of free fatty and bile acids by ileal glucagon-like peptide-1 secreting cells

Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding

Insights into agonist-elicited activation of the human glucose-dependent insulinotropic polypeptide receptor

A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus

Immunomodulation and inflammation: Role of GLP-1R and GIPR expressing cells within the gut

Single‐cell transcriptomics of human organoid‐derived enteroendocrine cell populations from the small intestine

Cellular mechanisms of incretin hormone secretion

The regulation of K- and L-cell activity by GLUT2 and the calcium-sensing receptor CasR in rat small intestine

Uncoupling Protein 2 Negatively Regulates Glucose-Induced Glucagon-Like Peptide 1 Secretion

Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes

Characterization and biological actions of N-terminal truncated forms of glucose-dependent insulinotropic polypeptide

Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells